A detailed history of Headlands Technologies LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Headlands Technologies LLC holds 18,450 shares of QURE stock, worth $223,060. This represents 0.03% of its overall portfolio holdings.

Number of Shares
18,450
Holding current value
$223,060
% of portfolio
0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$4.54 - $17.73 $83,763 - $327,118
18,450 New
18,450 $325,000
Q4 2023

Feb 02, 2024

SELL
$5.63 - $8.27 $9,306 - $13,670
-1,653 Reduced 35.56%
2,995 $20,000
Q3 2023

Nov 09, 2023

BUY
$6.71 - $11.83 $31,188 - $54,985
4,648 New
4,648 $31,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $565M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.